Jordan K - Search Results

1

Anthracycline extravasation injuries: management with dexrazoxane.

Jordan K, Behlendorf T, Mueller F, Schmoll HJ. Jordan K, et al. Ther Clin Risk Manag. 2009 Apr;5(2):361-6. doi: 10.2147/tcrm.s3694. Epub 2009 May 20. Ther Clin Risk Manag. 2009. PMID: 19536310 Free PMC article.

2

Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment.

Jordan K, Kasper C, Schmoll HJ. Jordan K, et al. Eur J Cancer. 2005 Jan;41(2):199-205. doi: 10.1016/j.ejca.2004.09.026. Eur J Cancer. 2005. PMID: 15661543 Review.

3

Successful treatment of mediastinal lymphomatoid granulomatosis with rituximab monotherapy.

Jordan K, Grothey A, Grothe W, Kegel T, Wolf HH, Schmoll HJ. Jordan K, et al. Eur J Haematol. 2005 Mar;74(3):263-6. doi: 10.1111/j.1600-0609.2004.00367.x. Eur J Haematol. 2005. PMID: 15693798

4

Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment.

Schmoll HJ, Aapro MS, Poli-Bigelli S, Kim HK, Park K, Jordan K, von Pawel J, Giezek H, Ahmed T, Chan CY. Schmoll HJ, et al. Among authors: jordan k. Ann Oncol. 2006 Jun;17(6):1000-6. doi: 10.1093/annonc/mdl019. Epub 2006 Mar 8. Ann Oncol. 2006. PMID: 16524979 Free article. Clinical Trial.

5

Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations.

Jordan K, Sippel C, Schmoll HJ. Jordan K, et al. Oncologist. 2007 Sep;12(9):1143-50. doi: 10.1634/theoncologist.12-9-1143. Oncologist. 2007. PMID: 17914084 Free article. Review.

6

Severe thrombocytosis and anemia associated with celiac disease in a young female patient: a case report.

Voigt W, Jordan K, Sippel C, Amoury M, Schmoll HJ, Wolf HH. Voigt W, et al. Among authors: jordan k. J Med Case Rep. 2008 Apr 1;2:96. doi: 10.1186/1752-1947-2-96. J Med Case Rep. 2008. PMID: 18380894 Free PMC article.

7

Venous access ports: frequency and management of complications in oncology patients.

Jordan K, Behlendorf T, Surov A, Kegel T, Maher G, Wolf HH. Jordan K, et al. Onkologie. 2008 Jul;31(7):404-10. doi: 10.1159/000140451. Epub 2008 Jun 20. Onkologie. 2008. PMID: 18596390 Review.

8

Safety and efficacy of a triple antiemetic combination with the NK-1 antagonist aprepitant in highly and moderately emetogenic multiple-day chemotherapy.

Jordan K, Kinitz I, Voigt W, Behlendorf T, Wolf HH, Schmoll HJ. Jordan K, et al. Eur J Cancer. 2009 May;45(7):1184-1187. doi: 10.1016/j.ejca.2008.11.046. Epub 2009 Jan 8. Eur J Cancer. 2009. PMID: 19135359

9

[New antiemetic strategies - not only in oncology].

Jordan K, Müller F, Schmoll HJ. Jordan K, et al. Internist (Berl). 2009 Jul;50(7):887-94. doi: 10.1007/s00108-009-2411-1. Internist (Berl). 2009. PMID: 19484194 Review. German.

10

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study.

Rapoport BL, Jordan K, Boice JA, Taylor A, Brown C, Hardwick JS, Carides A, Webb T, Schmoll HJ. Rapoport BL, et al. Among authors: jordan k. Support Care Cancer. 2010 Apr;18(4):423-31. doi: 10.1007/s00520-009-0680-9. Epub 2009 Jul 1. Support Care Cancer. 2010. PMID: 19568773 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,494 results

Search Page